4th Quarter - Report
THE MCMANUS GROUP for DENDREON PHARMACEUTICALS LLC
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support for H.R. 1176 - PSA Screening for HIM Act.
Foreign entity interest: Dendreon is a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Medicare/Medicaid MMM
Access to autologous cellular immunotherapies in Medicare Part B. Provisions included in Title I - Subtitle B of PL. 117-169/H.R. 5376 - Inflation Reduction Act of 2022.
Foreign entity interest: Dendreon is a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
| ALANNA TEMME | LD, Rep. Jon Porter |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.